neurodegenerative diseases

See the following -

How We Could Kill Superbugs Without Antibiotics

Charlie Sorrel | Co.Exist | March 1, 2016

Antibiotics will soon be useless, but U.K. scientists have come up with a new way to kill bacteria—and it's not with a drug. And perhaps the best thing about this approach is that bacteria may not be able to build resistance against it. A team from the University of East Anglia, publishing in the journal Nature, figured out that the key to destroying bacteria is understanding how they build their defensive walls. It’s like ruining an astronaut’s space suit instead of going after the astronauts inside...

Read More »

Oscars Of Science: Breakthrough Awards Hands Out $21m To Transform Physicists Into Rockstars

Tim Walker | The Independent | December 13, 2013

In Hollywood this week, the talk was all about the Golden Globe nominations, but several hundred miles to the north, Silicon Valley’s biggest names were enjoying a new kind of awards ceremony – and they invited one of the film industry’s favourite sons to host it. Read More »

This Is Your Brain On Gluten

James Hamblin | The Atlantic | December 20, 2013

The idea that gluten and carbohydrates are at the root of Alzheimer's disease, anxiety, depression, and ADHD has now reached millions of people. It is the basis of a number-one bestseller written by a respected physician. What is it worth? Read More »

UK Big Data Project To Capture Personal Data and Experiences Of Multiple Sclerosis Patients

Press Release | Imperial College London, Biogen Idec | December 11, 2014

Over an initial three year period, the OPTIMISE project will develop and deploy tools for collecting a wide range of data from people with MS in addition to routine clinical assessments. The project will work to integrate brain scans, genomics data, biomarkers from blood samples, self-reported quality of life measures and data from sensors that track movement into a single database. The project will initially pilot the tools through MS centres in Imperial and three other UK institutions before expanding access to the approach for researchers worldwide. Read More »